Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.89%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information
Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQERNEXA THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ERNA - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 19K | 3.89% | $ 488K |
| 3/31/2025 | $ 268K | 50.09% | $ 535K |
| 12/31/2024 | $ 365K | 62.71% | $ 582K |
| 9/30/2024 | $ 384K | 64.21% | $ 598K |
| 6/30/2024 | $ 365K | 225.31% | $ 162K |
| 3/31/2024 | $ 116K | 100.87% | $ 115K |
| 12/31/2023 | $ 19K | 27.94% | $ 68K |
| 9/30/2023 | $ -129K | 0% | $ 51K |
| 6/30/2023 | $ -86K | 0% | $ 0 |
| 3/31/2023 | $ 1K | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 3.01%.
- Over the past 5 years, ERNEXA THERAPEUTICS INC's average CapEx % has been 46.45%.
- The median CapEx % for ERNEXA THERAPEUTICS INC during this period was 17.33%
- ERNEXA THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 225.31%.
- The lowest CapEx % recorded by ERNEXA THERAPEUTICS INC in the same timeframe 3.01%
ERNEXA THERAPEUTICS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for ERNEXA THERAPEUTICS INC is calculated as follows: CapEx [ $ 295K ] / Revenues [ $ 9.79M ]
(=) CapEx % [ 3.01% ] ERNA - Capital Expenditures Margin, Last 5 years
3.01%
Minimum
Sep 30, 2020
225.31%
Maximum
Jun 30, 2024
46.45%
Average
17.33%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.02% |
| average | 3.47% |
| median | 2.43% |
| std | 3.27% |